VERU
Veru
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
VERU Profile
Veru Inc.
A biopharmaceutical company that developing novel medicines for COVID-19 and other viral ARDS-related diseases and oncology
2916 N. Miami Avenue, Suite 1000, Miami, Florida 33127
--
Veru Inc., founded in 1971. It is a late-stage clinical biopharmaceutical company focusing on the development of new drugs for the treatment of metabolic diseases, oncology, and ARDS. The company's drug development program includes two late-stage new chemical entities, enobosarm and sabizabulin.